Cruciferous vegetables Yes, vegetables are good for you, but some types of vegetables, especially the cruciferous, gas-producing kinds, can aggravate any GI side effects you may be having
including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use
Clinical trials have demonstrated reductions in hemoglobin A1c levels and weight loss that vary by dose and populationwith higher doses (such as Wegovy 2.4 mg) achieving approximately 15% weight loss in obesity trials, with more modest effects at lower doses used for diabetes
Hirsch, S
Slide from Katherine Tuttles presentation, during FLOW session, 61st European Renal Association Congress Conclusion The FLOW trial showed that semaglutide significantly decreased the risk of progression of kidney disease in T2DM, without significant increases in serious adverse events